APGE Apogee Therapeutics Inc. Common Stock
135.07USD0.00%Mkt Cap: 10.22B $P/E: —34d ago
Apogee Therapeutics, Inc. develops and commercializes biologic therapies for immunological and inflammatory (I&I) diseases for patients and caregivers. The company's pipeline includes products, such as ZUMILOKIBART (APG7…
Industry Peers
Biotechnology$127.54BUSDP/E 29.3
$81.13BUSD
$74.79BUSDP/E 18.0
$57.11BUSDP/E 34.8
$55.24BUSDP/E 36.1
$44.51BUSD
$41.63BUSDP/E 17.7
$41.14BUSDP/E 64.7
$32.74BUSDP/E 30.1
$29.42BUSDP/E 37.1
$25.84BUSD
$24.53BUSD
$24.01BUSDP/E 30.3
$23.13BUSDP/E 14.5
$22.67BUSD
$21.61BUSDP/E 29.3
$15.32BUSDP/E 16.2
$15.01BUSDP/E 17.5
$14.58BUSDP/E 18.6
$13.78BUSD
Key Statistics
Company
Market Cap10.22B USD
Enterprise Value9.22B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-255.84M USD
Revenue/Share—
Last Price135.07 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees261
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-26.00
PEG—
EV/EBITDA-28.63
EV/Revenue—
P/S—
P/B8.49
EPS (TTM)-4.34
EPS (Forward)-5.20
52W Range
35.39100% of range135.09
52W High135.09 USD
52W Low35.39 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.30%
ROA-27.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-227.45M USD
CapEx (TTM)5.15M USD
FCF Margin—
FCF Yield-1.42%
Net Debt-965.09M USD
Net Debt/EBITDA3.00
Balance Sheet
Debt/Equity0.01
Current Ratio26.44
Quick Ratio26.17
Book Value/Sh15.91 USD
Cash/Share12.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)134.62 USD
Upside (mean)-0.3%
Target Range133.00 USD – 135.11 USD
133.00-0.3% to mean135.11
# Analysts5
Ownership
Shares Out.62.20M
Float58.44M
Insiders2.31%
Institutions110.80%
Short Interest
Short Ratio3.6d
Short % Float7.28%
Short % Out.5.65%
Shares Short4.27M
Short (prev mo.)4.13M
Technical
SMA 50134.18 (+0.7%)
SMA 20093.12 (+45.1%)
Beta0.33
S&P 52W Chg14.58%
Avg Vol (30d)1.27M
Avg Vol (10d)1.43M
Technical Indicators
RSI (14)79.3
MACD1.6709
MACD Signal2.2642
MACD Hist.-0.5932
BB Upper135.27 USD
BB Middle134.64 USD
BB Lower134.01 USD
BB Width0.94%
ATR (14)0.4358 USD
Vol Ratio (20d)0.00x